Jacob Elkins

Jacob Elkins is a seasoned medical professional with extensive experience in research and clinical development, currently serving as the Chief Medical Officer and Senior Vice President of R&D at Sarepta Therapeutics since February 2020. Prior to this role, Jacob held multiple leadership positions at Biogen from August 2007, including Vice President of Research and Early Development, and was responsible for the Acute Neurology Research Unit and Neuroinflammation Development. Jacob's academic background includes serving as an Assistant Professor in the Stroke Sciences Group at the University of California, San Francisco, and practicing as an Attending Physician at UCSF Medical Center. Educational qualifications include a Doctor of Medicine from Harvard Medical School and a Master of Advanced Studies in Clinical Research from the University of California, San Francisco, along with a Bachelor of Arts degree from Princeton University.